arrow
M

Marc Suárez-Calvet

barcelona beta brain research center
H指数:57
被引数:1.4万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Sociodemographic and clinical characteristics of participants in blood p-tau217 studies for Alzheimer’s disease: A systematic review

阿尔茨海默病患者血液p-tau217研究参与者的社会人口学和临床特征:一项系统综述

2026-09-100
OAAI
Regional amyloid accumulation, post-traumatic distress, and intrusive symptoms in cognitively unimpaired older adults at risk for Alzheimer's

认知功能正常的阿尔茨海默病风险老年人群的区域性淀粉样蛋白积累、创伤后痛苦和闯入性症状

2026-09-010
OAAI
Neurobiological correlates of longitudinal grey matter volume changes in preclinical Alzheimer’s disease

阿尔茨海默病临床前期的神经生物学相关指标与灰质体积纵向变化

2026-08-210
OA
Clinical performance and effect of pre‐analytical variation of plasma pTau217 alone versus the plasma pTau217/Aβ42 ratio for the identification of amyloid pathology

血浆pTau217单独与血浆pTau217/Aβ42比值在识别淀粉样蛋白病理方面的临床性能及预分析变异的影响

2025-12-230
OAAI
Fluid biomarkers for neurodegenerative diseases: a comprehensive update

神经退行性疾病的流体生物标志物:综合更新

2025-12-200
OAAI
Sex differences in Alzheimer’s disease CSF biomarkers and their association with Aβ pathology on PET in cognitively unimpaired individuals

阿尔茨海默病患者脑脊液生物标志物的性别差异及其与PET上Aβ病理的关系,在认知功能未受损的个体中。

2025-10-310
OAAI
Polygenic proxies of age-related plasma protein levels reveal a role for Metalloproteinase inhibitor 2 (TIMP2) protein in cognitive performance

多基因代理揭示了与年龄相关的血浆蛋白水平中金属蛋白酶抑制剂2(TIMP2)蛋白在认知功能中的作用

2025-10-230
PRE
Synaptic dysfunction and glial activation markers throughout aging and early neurodegeneration: a longitudinal CSF biomarker-based study

突触功能障碍和胶质细胞激活标志物在衰老和早期神经退行性病变过程中的变化:一项基于脑脊液生物标志物的纵向研究

2025-10-190
OAAI
Longitudinal association of shorter leukocyte telomere length with CSF biomarker dynamics across early Alzheimer's disease stages in at-risk individuals

风险个体早期阿尔茨海默病阶段中,较短白细胞端粒长度与CSF生物标志物动态的纵向关联

2025-08-190
PREAI
The Global Neurodegeneration Proteomics Consortium: biomarker and drug target discovery for common neurodegenerative diseases and aging

全球神经变性蛋白质组学联盟: 常见神经退行性疾病和衰老的生物标志物和药物靶点发现

2025-07-150
OAAI
The potential dual role of tau phosphorylation: plasma phosphorylated-tau217 in newborns and Alzheimer's disease

tau磷酸化的潜在双重作用:新生儿和阿尔茨海默病中的血浆磷酸化-tau217

2025-01-017
OA
Data-driven CSF biomarker profiling: imaging and clinical outcomes in a cohort at risk of Alzheimer's disease

数据驱动的CSF生物标志物分析: 阿尔茨海默病风险队列的成像和临床结果

2024-12-230
OAAI
Plasma p-tau217 in Alzheimer's disease: Lumipulse and ALZpath SIMOA head-to-head comparison

阿尔茨海默氏病的血浆p-tau217: Lumipulse和ALZpath sim0a的头对头比较

BRAIN
IF11.7
2024-12-160
PRE
The CSF p-tau/β-amyloid 42 ratio correlates with brain structure and fibrillary β-amyloid deposition in cognitively unimpaired individuals at the earliest stages of pre-clinical Alzheimer's disease
2024-12-130
OAAI
Blood-brain barrier permeable β-blockers association with Alzheimer's disease cerebrospinal fluid biomarkers levels in non-demented individuals
2024-11-250
PRE
Biomarcadores en sangre para la enfermedad de Alzheimer: posicionamiento y recomendaciones de uso del Grupo de Estudio de Conducta y Demencias de la Sociedad Española de Neurología

血液中的阿尔茨海默病生物标志物:西班牙神经病学学会行为与痴呆研究小组的定位和使用建议

2024-11-210
OAAI